Back
ESC Premium Access

Prevalence and outcomes of prasugrel versus clopidogrel in patients with and without diabetes following percutaneous coronary intervention for acute coronary syndrome

Session: Poster session 2 - Clinical platelet studies
Topic: Thrombosis and platelets
Speaker: Doctor M. Faggioni (Philadelphia, US)
Event: ESC Congress 2016

Congress Presentation

Add to my library

Like

About the speaker

Doctor Michela Faggioni

Hospital of the University of Pennsylvania, Philadelphia (United States of America)
0 follower

24 more presentations in this session

Effect of pretreatment with P2Y12 receptor antagonists on mortality in patients undergoing PCI: A report from SCAAR

Speaker: Professor E. Omerovic (Gothenburg, SE)

Access
Abstract
Like
Thumbnail

Gender differences in oral antiplatelet treatment use - results from a nationwide cohort study of acute coronary syndrome patients in Finland

Speaker: Doctor V. Kyto (Turku, FI)

Access
Abstract
Slides
Like
Thumbnail

Platelet reactivity and outcomes after transcatheter aortic valve implantation

Speaker: Doctor L. Gross (Munich, DE)

Access
Abstract
Slides
Like
Thumbnail

Safety of a regional standardized protocol to optimize the use of most effective platelet inhibition in ACS treated with PCI : Final Results from the Multicenter Rijnmond Collective Cardiology Study

Speaker: Doctor M. Van Der Linden (Schiedam, NL)

Access
Abstract
Slides
Like
Thumbnail

Characteristics and safety outcomes in first-time users of the P2Y12 receptor antagonists clopidogrel, prasugrel and ticagrelor

Speaker: Associate Professor S. Johansson (Molndal, SE)

Access
Abstract
Slides
Like
Thumbnail

Access the full session

Poster session 2 - Clinical platelet studies

Speakers: Doctor M. Faggioni, Professor E. Omerovic, Doctor V. Kyto, Doctor L. Gross, Doctor M. Van Der Linden...
Access
Like
Thumbnail

About the event

Image

ESC Congress 2016

27 August - 31 August 2016

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources